Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AURACVE:CADNASDAQ:KODNYSE:MDV Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAURAAura Biosciences$7.22+1.8%$8.03$5.99▼$13.50$357.39M0.36170,851 shs108,191 shsCADColonial Coal InternationalC$2.12-1.9%C$2.31C$1.22▼C$2.57C$380.79M1.61119,657 shs56,819 shsKODKodiak Sciences$3.33-2.6%$5.21$1.37▼$9.80$174.86M2.15838,033 shs327,652 shsMDVModiv Industrial$15.10$15.41$10.44▼$19.12$138.47M-0.3126,765 shs33,242 shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAURAAura Biosciences+1.83%-0.55%-14.25%-3.48%-18.97%CADColonial Coal International-1.85%+3.41%-16.86%-1.40%+10.99%KODKodiak Sciences-2.63%-14.40%-46.72%-10.96%-32.86%MDVModiv Industrial0.00%+1.27%-5.98%+0.67%+36.90%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAURAAura Biosciences1.9376 of 5 stars3.50.00.00.03.42.50.6CADColonial Coal InternationalN/AN/AN/AN/AN/AN/AN/AN/AKODKodiak Sciences2.8176 of 5 stars2.90.00.04.61.23.31.3MDVModiv Industrial1.0969 of 5 stars0.03.01.70.00.61.71.9Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAURAAura Biosciences3.00Buy$21.00190.86% UpsideCADColonial Coal InternationalN/AN/AN/AN/AKODKodiak Sciences1.71Reduce$5.5065.17% UpsideMDVModiv IndustrialN/AN/AN/AN/ACurrent Analyst RatingsLatest BEM, KOD, AURA, CAD, and MDV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024KODKodiak SciencesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.00 ➝ $5.004/1/2024KODKodiak SciencesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.00(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAURAAura BiosciencesN/AN/AN/AN/A$4.58 per shareN/ACADColonial Coal InternationalN/AN/AC$0.02 per share108.57C$0.11 per shareN/AKODKodiak SciencesN/AN/AN/AN/A$5.07 per shareN/AMDVModiv Industrial$46.94M2.95$0.27 per share55.14$29.66 per share0.51Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAURAAura Biosciences-$76.41M-$1.92N/AN/AN/AN/A-42.20%-36.66%5/9/2024 (Estimated)CADColonial Coal International-C$9.82M-C$0.06N/A∞N/AN/A-55.19%-33.61%6/18/2024 (Estimated)KODKodiak Sciences-$260.49M-$4.96N/AN/AN/AN/A-80.20%-46.17%5/20/2024 (Estimated)MDVModiv Industrial-$6.61M-$1.42N/A9.932.17-14.09%-2.82%-1.27%5/20/2024 (Estimated)Latest BEM, KOD, AURA, CAD, and MDV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023KODKodiak Sciences-$0.86-$1.13-$0.27-$1.13N/AN/A3/27/2024Q4 2023AURAAura Biosciences-$0.39-$0.50-$0.11-$0.50N/AN/A3/4/202412/31/2023MDVModiv Industrial$0.38$0.03-$0.35-$0.29$12.53 million$12.29 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAURAAura BiosciencesN/AN/AN/AN/AN/ACADColonial Coal InternationalN/AN/AN/AN/AN/AKODKodiak SciencesN/AN/AN/AN/AN/AMDVModiv Industrial$1.157.62%N/AN/A N/ALatest BEM, KOD, AURA, CAD, and MDV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/20/2024MDVModiv Industrialmonthly$0.09587.1%6/28/20246/28/20247/25/20243/19/2024MDVModiv Industrialmonthly$0.09587.1%5/31/20245/31/20246/25/20243/18/2024MDVModiv Industrial$0.09584/29/20244/30/20245/28/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAURAAura BiosciencesN/A18.7618.76CADColonial Coal International0.1432.3914.48KODKodiak SciencesN/A6.936.93MDVModiv IndustrialN/A0.060.06OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAURAAura Biosciences96.75%CADColonial Coal International14.63%KODKodiak Sciences89.06%MDVModiv Industrial8.21%Insider OwnershipCompanyInsider OwnershipAURAAura Biosciences5.90%CADColonial Coal International27.00%KODKodiak Sciences45.40%MDVModiv Industrial4.60%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAURAAura Biosciences8849.50 million46.58 millionNot OptionableCADColonial Coal InternationalN/A179.62 millionN/ANot OptionableKODKodiak Sciences11652.51 million28.67 millionOptionableMDVModiv Industrial129.17 million8.75 millionNot OptionableBEM, KOD, AURA, CAD, and MDV HeadlinesSourceHeadlineMDV Modiv Industrial, Inc.seekingalpha.com - April 23 at 2:21 PMBuild A Basket Of Well-Performing, High-Paying Dividend Stocksfinance.yahoo.com - April 15 at 12:28 PMFirst City Investment Group, L Sells 704 Shares of Modiv Industrial, Inc. (NYSE:MDV) Stockinsidertrades.com - April 4 at 7:09 AMModiv Industrial, Inc. (NYSE:MDV) Major Shareholder Sells $12,179.20 in Stockmarketbeat.com - April 3 at 3:26 PMAaron Scott Halfacre Sells 1,030 Shares of Modiv Industrial, Inc. (NYSE:MDV) Stockinsidertrades.com - April 2 at 4:26 AMModiv Industrial, Inc. (NYSE:MDV) CEO Sells $17,643.90 in Stockmarketbeat.com - April 1 at 3:24 PM4 REITs With Enormous Gains Over The Past Month And Yearfinance.yahoo.com - March 29 at 4:45 AMModiv Inc. 7.375% CUM SER A declares $0.4609 dividendmsn.com - March 18 at 6:19 PMModiv Industrial Declares Quarterly Dividends for Preferred Shareholders and Monthly Distributions for Common Shareholdersbusinesswire.com - March 18 at 4:05 PMModiv Industrial: A 7.2% Dividend Yield From Made In The USAseekingalpha.com - March 17 at 9:02 AMModiv Industrial, Inc. (MDV) Q4 2024 Earnings Call Transcriptseekingalpha.com - March 6 at 6:55 PMModiv Inc. (NYSE:MDV) Q4 2024 Earnings Call Transcriptfinance.yahoo.com - March 5 at 10:34 AMBuy Rating Affirmed for Modiv Industrial on Strategic Repositioning and Solid Financialsmarkets.businessinsider.com - March 4 at 11:48 PMModiv Industrial Q4 AFFO Declines - Quick Factsmarkets.businessinsider.com - March 4 at 8:48 AMModiv Industrial Inc (MDV) Reports Mixed Results Amid Market Challengesfinance.yahoo.com - March 4 at 8:48 AMModiv Industrial Announces Fourth Quarter and Full Year 2023 Resultsbusinesswire.com - March 4 at 6:00 AM3 Reasons I Changed My Mind And Bought Modiv Industrialseekingalpha.com - February 28 at 12:59 PMModiv Industrial Stock (NYSE:MDV), Short Interest Reportbenzinga.com - February 22 at 7:15 PMModiv Industrial to Report Fourth Quarter 2023 Results on March 4thfinance.yahoo.com - February 20 at 9:34 AMModiv Industrial to Report Fourth Quarter 2023 Results on March 4thbusinesswire.com - February 20 at 6:00 AMWhile insiders own 19% of Modiv Industrial, Inc. (NYSE:MDV), individual investors are its largest shareholders with 72% ownershipfinance.yahoo.com - February 5 at 7:56 AMModiv goes ex dividend tomorrowmsn.com - January 30 at 1:15 AMStrength Seen in Modiv Industrial, Inc. (MDV): Can Its 7.1% Jump Turn into More Strength?finance.yahoo.com - January 25 at 12:34 PMModiv Industrial Inc. 7.375% Cum. Redeem. Perp. Pfd. Series Awsj.com - January 19 at 1:48 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains ImminentMichael Burry Picked a Winner With GEN Restaurant GroupApril 2, 2024 7:09 AMView Michael Burry Picked a Winner With GEN Restaurant GroupLithium Overdose: Can These 2 Lithium Stocks Recover in 2024? April 22, 2024 6:15 AMView Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024? SMART Global Gets 25% Discount: Analysts Lift TargetsApril 11, 2024 10:21 AMView SMART Global Gets 25% Discount: Analysts Lift TargetsAll Headlines Company DescriptionsAura BiosciencesNASDAQ:AURAAura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.Colonial Coal InternationalCVE:CADColonial Coal International Corp. engages in the acquisition, exploration, and development of coal properties in Canada. It owns a 100% interest in the Huguenot coal project, a coal project with seventeen licenses covering an area of approximately 7,592 hectares. The company also holds interest in Flatbed coal property with eight coal licenses covering approximately 9,077 hectares in the Liard Mining Division, northeastern British Columbia. Colonial Coal International Corp. is headquartered in Vancouver, Canada.Kodiak SciencesNASDAQ:KODKodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.Modiv IndustrialNYSE:MDVModiv Industrial, Inc. is an internally managed REIT that is focused on single-tenant net-lease industrial manufacturing real estate. The Company actively acquires critical industrial manufacturing properties with long-term leases to tenants that fuel the national economy and strengthen the nation's supply chains. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.